Session » Abstracts: Metabolic & Crystal Arthropathies – Basic & Clinical Science (2585–2590)
- 1:00PM-1:15PM
-
Abstract Number: 2585
The effect of prophylactic colchicine use on gene expression in gout
- 1:15PM-1:30PM
-
Abstract Number: 2586
Estimated Carrier Prevalence of HLA-B*58:01 Across Diverse Populations in the US and Globally
- 1:30PM-1:45PM
-
Abstract Number: 2587
Nanoencapsulated Sirolimus Plus Pegadricase Reduced Disease Burden in Patients With Uncontrolled Gout: Results From the Phase 3 DISSOLVE Trials
- 1:45PM-2:00PM
-
Abstract Number: 2588
Nanoencapsulated Sirolimus plus Pegadricase (NASP) Demonstrates a Reduction in Gout Flares: Results from the Phase 3 DISSOLVE Studies
- 2:00PM-2:15PM
-
Abstract Number: 2589
Multi-omics Integration Reveals Gut Microbiota–Metabolite Dysregulation in Gout with Metabolic Syndrome